Dora Visnjic Selected Research

Dora Visnjic Research Topics

9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 03/2009
5	Acute Promyelocytic Leukemia 01/2022 - 10/2014
5	Leukemia 10/2019 - 03/2009
3	Hematologic Neoplasms (Hematological Malignancy) 06/2022 - 10/2014
3	Myeloid Leukemia (Leukemia, Myelocytic) 01/2022 - 11/2012
3	Neoplasms (Cancer) 10/2019 - 09/2011
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022

5	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 09/2011
3	AICA ribonucleotide (ZMP)IBA 01/2022 - 01/2017
3	Sirolimus (Rapamycin)FDA Link 07/2015 - 09/2011
2	Checkpoint Kinase 1IBA 01/2022 - 10/2019
2	pyrimidineIBA 01/2022 - 10/2019
2	AMP-Activated Protein KinasesIBA 10/2019 - 10/2014
2	Adenosine Monophosphate (AMP)IBA 01/2017 - 10/2014
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2011 - 03/2009
1	Bendamustine Hydrochloride FDA Link 06/2022
1	Antineoplastic Agents (Antineoplastics)IBA 06/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022
1	Dihydroorotate DehydrogenaseIBA 01/2022
1	brequinarIBA 01/2022
1	purineIBA 10/2019
1	EnzymesIBA 10/2019
1	Glucose (Dextrose)FDA LinkGeneric 10/2019
1	Small Interfering RNA (siRNA)IBA 10/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2017
1	BiguanidesIBA 01/2017
1	Differentiation AntigensIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Arsenic Trioxide (Trisenox)FDA Link 07/2015
1	Cytostatic AgentsIBA 11/2012
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 11/2012
1	TOR Serine-Threonine KinasesIBA 09/2011
1	Mitogen-Activated Protein KinasesIBA 09/2011
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 09/2011
1	MTOR InhibitorsIBA 09/2011
1	NocodazoleIBA 03/2009
1	AphidicolinIBA 03/2009

7	Therapeutics 06/2022 - 03/2009